Professor, Pediatrics, University of Colorado School of Medicine
Pediatric Endocrinology
Dr. Philip S. Zeitler, MD
|
|
Give Review
Philip Zeitler works in the field of Pediatric Endocrinology. He researched medicine at Duke University School of Medicine. Duke University School of Medicine is a one of the best medicals schools. Duke University School of Medicine has a rank of 8 in research and a 29 in primary care Dr. Philip S. Zeitler is also published. He has 58 publications published. The lastest publication: "Type 2 diabetes in adolescents, no longer rare.'
Publications
- Clinical trials in youth-onset type 2 diabetes: needs, barriers, and options.
- Screening for type 2 diabetes and prediabetes in obese youth: evaluating alternate markers of glycemia - 1,5-anhydroglucitol, fructosamine, and glycated albumin.
- Presentation and effectiveness of early treatment of type 2 diabetes in youth: lessons from the TODAY study.
- Continuous Glucose Monitoring and its Relationship to Hemoglobin A1c and Oral Glucose Tolerance Testing in Obese and Prediabetic Youth.
- Hemoglobin A1c assay variations and implications for diabetes screening in obese youth.
- Congenital Adrenal Hyperplasia and the Second Newborn Screen.
- Stimulation of mitogen-activated protein kinase pathway in rat somatotrophs by growth hormone-releasing hormone.
- Autocrine/paracrine regulation of breast cancer cell proliferation by growth hormone releasing hormone via Ras, Raf, and mitogen-activated protein kinase.
- Characterization of the synthesis and release of prolactin by an enriched fraction of human decidual cells.
- Characterization of the synthesis and release of human placental lactogen and human chorionic gonadotropin by an enriched population of dispersed placental cells.
- "Who is the wise man?--The one who foresees consequences:". Childhood obesity, new associated comorbidity and prevention.
- Risk factors associated with glucocorticoid-induced adverse effects in children with severe asthma.
- Fracture prediction and the definition of Osteoporosis in children and adolescents: the ISCD 2007 Pediatric Official Positions.
- Localization of insulin-like growth factor binding protein-4 expression in the mouse uterus during the peri-implantation period.
- Advances in epidemiology and treatment of type 2 diabetes in children.
- Rhinocerebral mucormycosis complicated by internal carotid artery thrombosis in a pediatric patient with type 1 diabetes mellitus: a case report and review of the lite...
- Treatment of non-alcoholic fatty liver disease with metformin versus lifestyle intervention in insulin-resistant adolescents.
- Testosterone, obesity and insulin resistance in young males: evidence for an association between gonadal dysfunction and insulin resistance during puberty.
- Insulin resistance in adolescents with type 1 diabetes and its relationship to cardiovascular function.
- Addition of metformin to a lifestyle modification program in adolescents with insulin resistance.
- Elevated fasting triglycerides predict impaired glucose tolerance in adolescents at risk for type 2 diabetes.
- The metabolic syndrome and nonalcoholic fatty liver disease in children.
- ISPAD Clinical Practice Consensus Guidelines 2006-2007. Type 2 diabetes mellitus in the child and adolescent.
- Presence of the metabolic syndrome in obese adolescents predicts impaired glucose tolerance and nonalcoholic fatty liver disease.
- Characteristics of adolescents and youth with recent-onset type 2 diabetes: the TODAY cohort at baseline.
- Increased incidence of non-insulin-dependent diabetes mellitus among adolescents.
- Clinical presentation and treatment of type 2 diabetes in children.
- Congenital Hypothyroidism and the second newborn metabolic screening in Colorado, USA.
- Approach to the obese adolescent with new-onset diabetes.
- Health-related quality of life in adolescents with comorbidities related to obesity.
- Treatment options for type 2 diabetes in adolescents and youth: a study of the comparative efficacy of metformin alone or in combination with rosiglitazone or lifestyl...
- Considerations regarding the diagnosis and treatment of childhood type 2 diabetes.
- Prevention and screening for type 2 diabetes in youth.
- The global spread of type 2 diabetes mellitus in children and adolescents.
- Insulin resistance, obesity, and related Disorders among black adolescents.
- Treatment of symptomatic pediatric Osteoporosis with cyclic single-day intravenous pamidronate infusions.
- Barriers to the treatment of adolescent type 2 diabetes--a survey of provider perceptions.
- The type 2 family: a setting for development and treatment of adolescent type 2 diabetes mellitus.
- Advances in the recognition and treatment of endocrine complications in children with chronic illness.
- Food and levothyroxine administration in infants and children.
- Update on nonautoimmune diabetes in children.
- Hyperglycemic hyperosmolar syndrome in children: pathophysiological considerations and suggested guidelines for treatment.
- Advances in the diagnosis and treatment of Osteoporosis.
- A rose is a rose is a rose--or is it?
- Osteoporosis in pediatrics.
- Acute necrotizing pancreatitis in an adolescent with type 2 diabetes.
- Diabetic ketoacidosis among obese African-American adolescents with NIDDM.
- Acute and chronic complications of type 2 diabetes mellitus in children and adolescents.
- Type 2 diabetes in adolescents, no longer rare.
- Using the electronic medical record to improve education in patients at risk for adrenal insufficiency.
- Antagonism of endogenous growth hormone-releasing hormone (GHRH) leads to reduced proliferation and apoptosis in MDA231 breast cancer cells.
- Functional GHRH receptor carboxyl terminal isoforms in normal and dwarf (dw) rats.
- Acquired growth hormone deficiency in a girl with chronic myelogenous leukemia treated with tyrosine kinase inhibitor therapy.
- Exercise for the treatment of childhood obesity--is it simply too much to ask?
- 48,XXYY, 48,XXXY and 49,XXXXY syndromes: not just variants of Klinefelter syndrome.
- Editorial: School-based intervention to reduce obesity and diabetes risks: small steps for a big problem.
- Clinical problem-solving. The importance of a name.
Schools
Duke University School Of Medicine
Seattle Children39s Hospital
Conditions Treated
- Hyperlipidemia
- Hypothyroidism
- Lipid Disorders
- Menstrual Disorders (incl. Dysmenorrhea)
- View All
Doctors Specialties
- Pediatric Endocrinology
Accepted Insurances
Education
-
Cincinnati Children's Hospital Medical Center -
University of Washington -
Duke University School of Medicine
Hospital
-
University of Colorado Hospital -
Children's Hospital Colorado
Helpful Reviews
Similar Doctors
|
Dr. Raj R. Wadwa, MD |
|
|
Dr. Margaret M. Kelsey, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Sharon H. Travers, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jennifer M. Barker, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Georgeanna J. Klingensmith, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
Dr. Shikha S. Sundaram, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christina M. Chambers, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jennifer K. Raymond, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrea M. Gerard Gonzalez, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christine M. Chan, MD |
|
|
Dr. Howard P. Chase, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Andrea K. Steck, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Natalie J. Nokoff, MD |